Aurora Cannabis (ACB) Stock Price & Analysis

ACB$4.94-0.05 -1.00%
Drug Manufacturers - Specialty & Generic
Compare
Market cap$324.78MEnterprise value$419.03MRevenue (TTM)$285.88MMarket position—

Score

45
Neutral
Value
58
Quality
30
Growth
48

AI Analysis

Snapshot

Aurora Cannabis is a mixed profile at 45/100 — Value 58, Growth 48, Quality 30. Under the hood: revenue compounding ~14% annually over recent years.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

58
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

48
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

30
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

Aurora Cannabis Inc. (ACB) last printed $4.94. Equity value is $324.78M. Trailing earnings multiple —. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2017201820192020202120222023202420252026
$18.07M$55.2M$245.54M$268.7M$245.25M$221.34M$223.8M$270.28M$343.29M$320.59M

About

Aurora Cannabis Inc. is a leading company in the global cannabis industry, focusing on the cultivation, production, and sale of various cannabis and cannabis-derived products across Canada and internationally. Beyond its core product offerings, the company engages in a broad spectrum of related activities, including the design and engineering of facilities, cannabis breeding programs, research and development, and both wholesale and retail distribution channels. For medical users, Aurora provides a diverse selection of products such as different strains of dried cannabis, cannabis oils, capsules, and topical kits. Their inventory also includes ancillary items like vaporizers, vaporizer accessories, herb mills (specifically for CanniMed products), grinders, and secure containers for vaporizers. The company is actively involved in developing advanced medical cannabis products, with ongoing work on oral, topical, edible, and inhalable formulations. Furthermore, Aurora manages CanvasRX, a network of centers dedicated to cannabis counseling and community outreach. Its service portfolio extends to providing patient support, specialized design and construction services, and comprehensive analytical testing for cannabis products. Aurora Cannabis Inc. manages an extensive collection of brands, including Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. The company's main corporate office is located in Edmonton, Canada.

Aurora Cannabis (ACB) Stock Price & Analysis

ACB price $4.94 -0.05 -1.00%

Ticker
ACB
Price
$4.94
Change
-0.05 -1.00%
Market cap
$324.78M
Forward P/E
40.06
Dividend yield
0.00%
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stocklytics score
45
Value
58
Quality
30
Growth
48

Stocklytics score rationale: value 58, quality 30, growth 48.

Insights · Forecast · Financials · Learn

Stocklytics home · Screener